SCHEMBL4617

SCHEMBL4617

CC(C)[C@]1(O)CC[C@]2(CCN(c3ccc(C(F)(F)F)cc3)C2)CC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.42
TSHR P16473 5/20 0.42
HIF1A Q16665 4/20 0.42
USP2 O75604 3/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2D6 P10635 2/20 0.42
HSD17B10 Q99714 1/20 0.39
CA12 O43570 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CYP1A2 P05177 1/20 0.38
HSD11B1 P28845 1/20 0.37
AKR1C3 P42330 1/20 0.36
NOTUM Q6P988 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MGLL Q99685 1/20 0.35
CYP2C19 P33261 1/20 0.35
MLYCD O95822 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5548 0.88 CYP3A4 (0.36) CYP3A4TSHRHIF1AUSP2CYP2C9
SCHEMBL11842 0.84 LIPE (0.35) CYP3A4TSHRHIF1AUSP2CYP2C9
SCHEMBL5301 0.84 EPHX2 (0.42)
SCHEMBL5569 0.79 USP2 (0.41) CYP3A4TSHRHIF1AUSP2CYP2C9
SCHEMBL16730388 0.77 CYP3A4 (0.43) CYP3A4TSHRHIF1AUSP2CYP2C9
SCHEMBL4615 0.75 HSD11B1 (0.42) CYP3A4TSHRHIF1AUSP2CYP2C9
SCHEMBL14996492 0.75 CYP3A4 (0.44) CYP3A4TSHRHIF1AUSP2CYP2C9
SCHEMBL20455752 0.75 CYP3A4 (0.49) CYP3A4TSHRHIF1AUSP2CYP2C9
SCHEMBL5214 0.73 S1PR1 (0.40) CYP3A4TSHRHIF1AUSP2CYP2C9
SCHEMBL11947830 0.72 CA12 (0.41) CYP3A4TSHRHIF1AUSP2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed